Resource Logo
CDC HIV/AIDS/Viral Hepatitis/STD/TB Prevention News Update

RUSSIA: Russia's Drug-Resistant TB Spreading More Easily




 

Nature (01.27.2014)

The journal Nature reported that drug-resistant TB strains in Russia are not only resistant to antibiotics, but also are able to spread more effectively. In a study of TB genomes in Samara, Russia, researchers, including Francis Drobniewski, a microbiologist at Queen Mary University in London, England, used TB isolates from 2,348 patients and conducted whole-genome sequencing on 1,000 of them. The researchers identified mutations linked to antibiotic resistance, and “compensatory mutations” that improved the ability of drug-resistant TB to spread. Approximately half of the TB isolates were multidrug-resistant (resistant to the two first-line anti-TB drugs) and 16 percent of the isolates contained mutations that made them also resistant to second-line drugs. In addition to resisting antibiotics by blocking essential functions in bacteria such as making proteins or building cell walls, drug-resistant strains develop mutations that make bacteria divide more slowly. In this study, the bacteria had developed compensatory mutations that restore the ability to divide quickly. The researchers found these mutations in more than 400 drug-resistant isolates that were resistant to rifampicin, a first-line anti-TB drug. Christopher Dye, an epidemiologist with the World Health Organization, noted that public-health officials still can control these strains by correctly identifying the patient’s strain and treating it with the most effective drug regimens, thus reducing the number of resistant cases. He stated that this method worked in Estonia, Hong Kong, the United States, and elsewhere. The full report, “Evolution and Transmission of Drug-Resistant Tuberculosis in a Russian Population,” was published online in the journal Nature Genetics (2014; doi:10.1038/ng.2878).



 


Copyright © 2014 -CDC Prevention News Update, Publisher. All rights reserved to Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.



Information in this article was accurate in January 27, 2014. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.